Trevi Announces License Agreements for use of Nalbuphine for the Treatment of LID in Parkinson’s Disease Read more
argenx and Halozyme enter global collaboration and license agreement for ENHANZE technology Read more
GeneQuantum and MITRO Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates Read more